A perspective published in PLOS Medicine by Chao, Gilden, and Wadden notes that GLP-1 and dual-agonist therapies have transformed obesity care, with efficacy that rivals some bariatric procedures in selected trials as demonstrated in major Phase 3 programs while the system-level challenges of capacity, monitoring, and access remain significant
Integrated control of predatory hunting by the central nucleus of the amygdala
The FDA said it aims to block the importation of potentially dangerous versions of the APIs used in compounded GLP-1s
Study of the Protective Effect of Teucrium polium L
Karger, Basel, pp 273286 Hori Y, Kawashima M, Oohara K et al (1984) Acquired, bilateral nevus of Ota-like macules